Elutia to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Elutia (Nasdaq: ELUT), a drug-eluting biomatrix technologies company, has announced its participation in three upcoming investor conferences in New York this September.

The company's leadership, including CEO Dr. Randy Mills and CFO Matt Ferguson, will attend the Cantor Global Healthcare Conference (Sept. 4), the H.C. Wainwright Global Investment Conference (Sept. 10), and the Lake Street Capital Markets Best Ideas Growth Conference (Sept. 11). The first two events will feature fireside chats and presentations, while the Lake Street conference will focus on one-on-one meetings.

News Market Reaction

-7.92% 2.6x vol

5 alerts

-7.92% News Effect

+3.5% Peak Tracked

-3.7% Trough Tracked

-$9M Valuation Impact

$100M Market Cap

2.6x Rel. Volume

On the day this news was published, ELUT declined 7.92%, reflecting a notable negative market reaction. Argus tracked a peak move of +3.5% during that session. Argus tracked a trough of -3.7% from its starting point during tracking. Our momentum scanner triggered 5 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $9M from the company's valuation, bringing the market cap to $100M at that time. Trading volume was elevated at 2.6x the daily average, suggesting increased selling activity.

Data tracked by StockTitan Argus on the day of publication.

GAITHERSBURG, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, President and Chief Executive Officer, and Matt Ferguson, Chief Financial Officer, will participate in the following upcoming investor conferences in New York:

Cantor Global Healthcare Conference
Format: Fireside Chat and 1x1 Meetings
Fireside Chat Date and Time: Thursday, September 4, 2025, 9:45 a.m. ET
Webcast Link: Click Here

H.C. Wainwright 27th Annual Global Investment Conference
Format: Presentation and 1x1 Meetings
Presentation Date and Time: Wednesday, September 10, 2025, 9:30 a.m. ET
Webcast Link: Click Here

Lake Street Capital Markets 9th Annual Best Ideas Growth Conference
Format: 1x1 Meetings
Date: Thursday, September 11, 2025

Institutional investors interested in scheduling a meeting may contact their Cantor, H.C. Wainwright, or Lake Street representative or email IR@elutia.com.

About Elutia
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.

Investors:
Matt Steinberg
FINN Partners
matt.steinberg@finnpartners.com

This press release was published by a CLEAR® Verified individual.

FAQ

When is Elutia (ELUT) presenting at the Cantor Global Healthcare Conference 2025?

Elutia will participate in a fireside chat at the Cantor Global Healthcare Conference on Thursday, September 4, 2025, at 9:45 a.m. ET.

Who will represent Elutia at the upcoming investor conferences?

Dr. Randy Mills (President and CEO) and Matt Ferguson (CFO) will represent Elutia at the conferences.

What type of presentation will Elutia give at the H.C. Wainwright Conference?

Elutia will deliver a presentation at the H.C. Wainwright Conference on Wednesday, September 10, 2025, at 9:30 a.m. ET, along with 1x1 meetings.

How can investors schedule meetings with Elutia management?

Institutional investors can schedule meetings by contacting their Cantor, H.C. Wainwright, or Lake Street representative or by emailing IR@elutia.com.